Gouttefangeas C - Search Results

1

Targeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapy.

Bedke J, Gouttefangeas C, Singh-Jasuja H, Stevanović S, Behnes CL, Stenzl A. Bedke J, et al. Among authors: gouttefangeas c. World J Urol. 2014 Feb;32(1):31-8. doi: 10.1007/s00345-013-1033-3. Epub 2013 Feb 12. World J Urol. 2014. PMID: 23404195 Free PMC article. Review.

2

Thrombocyte HLA molecules retain nonrenewable endogenous peptides of megakaryocyte lineage and do not stimulate direct allocytotoxicity in vitro.

Gouttefangeas C, Diehl M, Keilholz W, Hörnlein RF, Stevanović S, Rammensee HG. Gouttefangeas C, et al. Blood. 2000 May 15;95(10):3168-75. Blood. 2000. PMID: 10807784 Free article.

3

Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach.

Schirle M, Keilholz W, Weber B, Gouttefangeas C, Dumrese T, Becker HD, Stevanović S, Rammensee HG. Schirle M, et al. Among authors: gouttefangeas c. Eur J Immunol. 2000 Aug;30(8):2216-25. doi: 10.1002/1521-4141(2000)30:8<2216::AID-IMMU2216>3.0.CO;2-7. Eur J Immunol. 2000. PMID: 10940913 Free article.

4

Human platelets express heat shock protein receptors and regulate dendritic cell maturation.

Hilf N, Singh-Jasuja H, Schwarzmaier P, Gouttefangeas C, Rammensee HG, Schild H. Hilf N, et al. Among authors: gouttefangeas c. Blood. 2002 May 15;99(10):3676-82. doi: 10.1182/blood.v99.10.3676. Blood. 2002. PMID: 11986223 Free article.

5

High frequency of human cytomegalovirus (HCMV)-specific CD8+ T cells detected in a healthy CMV-seropositive donor.

Lang KS, Moris A, Gouttefangeas C, Walter S, Teichgräber V, Miller M, Wernet D, Hamprecht K, Rammensee HG, Stevanovic S. Lang KS, et al. Among authors: gouttefangeas c. Cell Mol Life Sci. 2002 Jun;59(6):1076-80. doi: 10.1007/s00018-002-8488-5. Cell Mol Life Sci. 2002. PMID: 12169019 Free PMC article.

6

Integrated functional genomics approach for the design of patient-individual antitumor vaccines.

Weinschenk T, Gouttefangeas C, Schirle M, Obermayr F, Walter S, Schoor O, Kurek R, Loeser W, Bichler KH, Wernet D, Stevanović S, Rammensee HG. Weinschenk T, et al. Among authors: gouttefangeas c. Cancer Res. 2002 Oct 15;62(20):5818-27. Cancer Res. 2002. PMID: 12384544

7

Towards patient-specific tumor antigen selection for vaccination.

Rammensee HG, Weinschenk T, Gouttefangeas C, Stevanović S. Rammensee HG, et al. Among authors: gouttefangeas c. Immunol Rev. 2002 Oct;188:164-76. doi: 10.1034/j.1600-065x.2002.18815.x. Immunol Rev. 2002. PMID: 12445290 Review.

8

CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors.

Dittmann J, Keller-Matschke K, Weinschenk T, Kratt T, Heck T, Becker HD, Stevanović S, Rammensee HG, Gouttefangeas C. Dittmann J, et al. Among authors: gouttefangeas c. Cancer Immunol Immunother. 2005 Aug;54(8):750-8. doi: 10.1007/s00262-004-0640-7. Epub 2004 Dec 22. Cancer Immunol Immunother. 2005. PMID: 15614528 Free PMC article.

9

High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donors.

Walter S, Bioley G, Bühring HJ, Koch S, Wernet D, Zippelius A, Pawelec G, Romero P, Stevanović S, Rammensee HG, Gouttefangeas C. Walter S, et al. Among authors: gouttefangeas c. Eur J Immunol. 2005 Oct;35(10):2876-85. doi: 10.1002/eji.200526207. Eur J Immunol. 2005. PMID: 16134083 Free article.

10

Immunotherapy of renal cell carcinoma.

Gouttefangeas C, Stenzl A, Stevanović S, Rammensee HG. Gouttefangeas C, et al. Cancer Immunol Immunother. 2007 Jan;56(1):117-28. doi: 10.1007/s00262-006-0172-4. Epub 2006 May 5. Cancer Immunol Immunother. 2007. PMID: 16676181 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters